Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Y. Gzam"'
Autor:
S. Chekili, K. Ben Abdelghani, K. Ouenniche, Y. Gzam, L. Souabni, L. Ahmed, A. Fazaa, Moncef Sellami, S. Miladi, S. Kassab
Publikováno v:
Revue du Rhumatisme. 88:A264-A265
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
S. Miladi, S. Kassab, S. Chekili, A. Fazaa, Y. Gzam, L. Souabni, K. Ben Abdelghani, K. Ouenniche, Moncef Sellami, L. Ahmed
Publikováno v:
Revue du Rhumatisme. 88:A264
Autor:
Wafa Hamdi, W. Triki, H. Riahi, H. Ferjani, Kaouther Maatallah, M. Chelly-Bouaziz, Dhia Kaffel, Y. Gzam
Publikováno v:
Revue du Rhumatisme. 87:A179-A180
Introduction Quoique la paroi thoracique anterieure (PTA) soit frequemment touchee au cours de la spondylarthrite (SpA), les caracteristiques cliniques et radiologiques de cette localisation sont peu decrites dans la litterature. L’objectif de cett
Publikováno v:
Revue du Rhumatisme. 87:A257
Introduction Bien que superficielle et accessible a l’examen clinique, l’articulation sternoclaviculaire (SC) est souvent oubliee. Les douleurs d’origine sternoclaviculaire peuvent etre trompeuses, et miment une douleur viscerale ou cervicale.
Autor:
S. Chekili, S. Kassab, L. Souabni, K. Ouenniche, S. Miladi, A. Fazaa, A. Laatar, K. Ben Abdelghani, Y. Gzam
Publikováno v:
Annals of the Rheumatic Diseases. 79:1613.2-1613
Background:The advent of biologics targeting tumor necrosis factor-alpha (anti-TNF alpha) has revolutionized the treatment of spondyloarthritis (SpA). Their association with conventional synthetic disease-modifying antirheumatic drugs (cs-DMARD), alt
Autor:
S. Kassab, S. Chekili, L. Souabni, A. Laatar, K. Ben Abdelghani, Y. Gzam, S. Miladi, A. Fazaa, K. Ouenniche
Publikováno v:
Annals of the Rheumatic Diseases. 79:1629.2-1629
Background:Axial spondyloarthritis (ax-SpA) is a chronic rheumatic disease that mainly affects men. However, the female form of ax-SpA remains insufficiently studied.Objectives:The aim of this study was to determine the clinical characteristics, the
Autor:
L. Souabni, S. Chekili, A. Fazaa, K. Ouenniche, Y. Gzam, S. Kassab, K. Ben Abdelghani, S. Miladi, A. Laatar
Publikováno v:
Annals of the Rheumatic Diseases. 79:1629.1-1629
Background:In the literature, non radiographic axial Spondyloarthritis (nr-SpA) is predominantly female with a shorter period of evolution and similar peripheral manifestations to radiographic axial spondyloarthritis (r-SpA). However, we do not have
Autor:
A. Fazaa, S. Miladi, L. Souabni, K. Ouenniche, A. Laatar, Y. Gzam, S. Kassab, K. Ben Abdelghani, S. Chekili
Publikováno v:
Annals of the Rheumatic Diseases. 79:1613.3-1614
Background:Tumour necrosis factor blockers (anti-TNFs) are typically used in axial spondyloarthritis (ax-SpA) when the disease has not responded adequately to conventional therapy. However, the effects of the comedication conventional synthetic disea
Autor:
L. Souabni, S. Chekili, S. Miladi, A. Fazaa, A. Laatar, K. Ben Abdelghani, S. Kassab, Y. Gzam, K. Ouenniche
Publikováno v:
Annals of the Rheumatic Diseases. 79:1613.1-1613
Background:For decades, NSAID have been used as the first-line drugs to treat axial spondyloarthritis (ax-SpA). However, the NSAID prescription strategy is not clearly detailed and it varies from one clinician to another.Objectives:The aim of this st